YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells

被引:1
作者
Noguera, Nelida Ines [1 ,2 ]
Travaglini, Serena [1 ,2 ]
Scalea, Stefania [3 ]
Catalanotto, Caterina [4 ]
Reale, Anna [4 ]
Zampieri, Michele [4 ]
Zaza, Alessandra [2 ,5 ]
Ricciardi, Maria Rosaria [6 ]
Angelini, Daniela Francesca [7 ]
Tafuri, Agostino [6 ]
Ottone, Tiziana [1 ,2 ]
Voso, Maria Teresa [1 ,2 ]
Zardo, Giuseppe [3 ]
机构
[1] Tor Vergata Univ, Dept Biomed & Prevent, I-00133 Rome, Italy
[2] St Lucia Fdn IRCCS, Unit Neurooncoematol, I-00143 Rome, Italy
[3] Sapienza Univ, Dept Expt Med, I-00185 Rome, Italy
[4] Sapienza Univ, Dept Mol Med, I-00185 Rome, Italy
[5] Sapienza Univ, Dept Med & Surg Sci & Biotechnol, I-00185 Rome, Italy
[6] Sapienza Univ, Dept Clin & Mol Med, I-00185 Rome, Italy
[7] St Lucia Fdn IRCCS, Lab Neuroimmunol & Cytofluorimetry, I-00143 Rome, Italy
关键词
YY1; acute myeloid leukemia; C; EBPs; RAR & alpha; all-trans retinoic acid; Polycomb proteins; ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; YIN YANG 1; TRANSCRIPTIONAL REGULATOR YIN-YANG-1; ACUTE MYELOGENOUS LEUKEMIA; TRANS-RETINOIC ACID; SELF-RENEWAL; MYELODYSPLASTIC SYNDROMES; HEMATOPOIETIC-CELLS; SKELETAL MYOGENESIS;
D O I
10.3390/cancers15154010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acute myeloid leukemia (AML) is characterized by the expansion of clonally derived hematopoietic precursors undergoing a partial or complete maturation block. De novo AML is characterized by recurrent cytogenetic alterations such as chromosomal translocations. However, in the recent past, it was shown that several somatic mutations and epigenetic alterations also contribute to AML onset and progression. Epigenetic mechanisms regulate the equilibrium between self-renewal and differentiation of hematopoietic stem cells and precursors. In this context, Polycomb-group (PcG) proteins regulate the expression of genes involved in cell-cycle regulation and differentiation, and aberrant expression and/or mutations of PcG genes have been shown to occur in hematopoietic neoplasms.In this study we analyzed the expression of Yin and Yang 1 protein (YY1), a member of the noncanonical PcG complexes, in AML patient samples and AML cell lines and the effect of YY1 downregulation on the AML differentiation block. Our results show that YY1 is significantly overexpressed in AML patient samples and AML cell lines and that YY1 knockdown relieves the differentiation block. YY1 downregulation in two AML cell lines (HL-60 and OCI-AML3) and one AML patient sample restored the expression of members of the CEBP protein family, increased the expression of extrinsic growth factors/receptors and surface antigenic markers, induced morphological cell characteristics typical of myeloid differentiation, and sensitized cells to retinoic acid treatment and to apoptosis. Overall, our data show that YY1 is not a secondary regulator of myeloid differentiation but that, if overexpressed, it can play a predominant role in myeloid differentiation block.
引用
收藏
页数:22
相关论文
共 115 条
  • [1] The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
    Agrawal, Shuchi
    Hofmann, Wolf-Karsten
    Tidow, Nicola
    Ehrich, Mathias
    van den Boom, Dirk
    Koschmieder, Steffen
    Berdel, Wolfgang E.
    Serve, Hubert
    Mueller-Tidow, Carsten
    [J]. BLOOD, 2007, 109 (09) : 3895 - 3905
  • [2] DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
    Anh Tram Nguyen
    Taranova, Olena
    He, Jin
    Zhang, Yi
    [J]. BLOOD, 2011, 117 (25) : 6912 - 6922
  • [3] Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia
    Antonio-Andres, Gabriela
    Martinez-Ruiz, Gustavo U.
    Morales-Martinez, Mario
    Jimenez-Hernandez, Elva
    Martinez-Torres, Estefany
    Lopez-Perez, Tania V.
    Estrada-Abreo, Laura A.
    Patino-Lopez, Genaro
    Juarez-Mendez, Sergio
    Davila-Borja, Victor M.
    Huerta-Yepez, Sara
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [4] Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene
    Antonio-Andres, Gabriela
    Rangel-Santiago, Jesus
    Tirado-Rodriguez, Belen
    Martinez-Ruiz, Gustavo U.
    Klunder-Klunder, Miguel
    Vega, Mario I.
    Lopez-Martinez, Briceida
    Jimenez-Hernandez, Elva
    Torres Nava, Jose
    Medina-Sanson, Aurora
    Huerta-Yepez, Sara
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2628 - 2638
  • [5] Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms
    Asada, Shuhei
    Kitamura, Toshio
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (02) : 179 - 186
  • [6] Transcription factor YY1 functions as a PcG protein in vivo
    Atchison, L
    Ghias, A
    Wilkinson, F
    Bonini, N
    Atchison, ML
    [J]. EMBO JOURNAL, 2003, 22 (06) : 1347 - 1358
  • [7] Assembly and Interrogation of Alzheimer's Disease Genetic Networks Reveal Novel Regulators of Progression
    Aubry, Soline
    Shin, William
    Crary, John F.
    Lefort, Roger
    Qureshi, Yasir H.
    Lefebvre, Celine
    Califano, Andrea
    Shelanski, Michael L.
    [J]. PLOS ONE, 2015, 10 (03):
  • [8] Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts
    Baumgartner, B
    Weber, M
    Quirling, M
    Fischer, C
    Page, S
    Adam, M
    von Schilling, C
    Waterhouse, C
    Schmid, C
    Neumeier, D
    Brand, K
    [J]. LEUKEMIA, 2002, 16 (10) : 2062 - 2071
  • [9] Beà S, 2001, CANCER RES, V61, P2409
  • [10] Clinical Effect of Point Mutations in Myelodysplastic Syndromes
    Bejar, Rafael
    Stevenson, Kristen
    Abdel-Wahab, Omar
    Galili, Naomi
    Nilsson, Bjoern
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    Raza, Azra
    Levine, Ross L.
    Neuberg, Donna
    Ebert, Benjamin L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) : 2496 - 2506